Recombinant follicle-stimulating hormone stimulates ovarian androgen synthesis in down-regulated ovulatory women

References

• Fevold HL. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secre-tion. Endocrinology 1941;28:33–6
   Google Scholar
• Falck B. Site of production of oestrogen in rat ovaries studied in micro-transplants. Acta Physiol Scand 1959;47\(Supp1163):5–101
   Google Scholar
• Ryan KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombined ovarian granulosa and theca cells. J Clin Endocrinol Metab 1968;28:355–8
   Google Scholar
• Chryssikopoulos A. The potential role of intra-ovarian factors on ovarian androgen production. Ann NY Acad Sci 2000;900:184–92
   PubMed Web of Science ®Google Scholar
• Fleming R, Coutts JR. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226–30
   PubMed Web of Science ®Google Scholar
• Mitchell R, Buckler HM, Matson P, et al. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon). Hum Reprod 1996;11:962–7
   PubMed Web of Science ®Google Scholar
• Dale PO, Tanbo T, Abyholm T. Endometriosis-ass ociated infertility treated by long-term gonadotropin-releasing hormone agonist adminis-tration and assisted fertilization. J In-Vitro Fert Embryo Transf 1990;7:180–1
   Google Scholar
• Ben-Chetrit A, Gotlieb L, Wong PY, et al. Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women: examination of the two cell, two gonadotropin theory. Fertil Steril 1996;65:711–17
   Google Scholar
• Couzinet B, Lestrat N, Brailly S, et al. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552–6
   PubMed Web of Science ®Google Scholar
• Schoot DC, Co elingh Bennink HJ, Mannaerts BM, et al. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab 1992;74:1471–3
   PubMed Web of Science ®Google Scholar
• Harlin J, Khan SA, Diczfalusy E. Molecular composition of luteinizing hormone and follicle-stimulating hormone in commercial gonadotropin preparations. Fertil Steril 1986;46:1055–61
   Google Scholar
• Tanbo T, Dale PO, Kjekshus E, et al. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil Steril 1990;53:798–802
   PubMed Web of Science ®Google Scholar
• Lobo RA, Kletzky OA, Campeau JD, et al. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil Steril 1983;39:674–8
   PubMed Web of Science ®Google Scholar
• Fauser BC, Pache TD, Lamberts SW, et al. Serum bioactive and immunoreactive luteinizing hor-mone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J. Clin Endocrinol Metab 1991;73:811–17
   PubMed Web of Science ®Google Scholar
• Martin KA, Hornstein MD, Taylor AE, et al. Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles. Fertil Steril 1997;68:1011–16
   PubMed Web of Science ®Google Scholar
• Recombinant human FSH study group. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995;63:77–86
   PubMed Web of Science ®Google Scholar
• Out HJ, Mannaerts BM, Driessen SG, et al. A prospective, randomized, assessor blind, multi-center study comparing recombinant and urinary follicle-stimulating hormone in in vitro fertiliza-tion. Hum Reprod 1995;10:2534–40
   PubMed Web of Science ®Google Scholar
• Dale PO, Tanbo T, Djosseland 0, et al. Persistance of hyperinsulinemia in polycystic ovarian syn-drome after ovarian suppression by GnRH-agonist. Acta Endocrinol (Copenh) 1992;126:132–6
   Google Scholar
• Dale PO, Tanbo T, Haug E, et al. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hor-mone in women with polycystic ovary syndrome. Hum Reprod 1998;13:567–70
   PubMed Web of Science ®Google Scholar
• Mannaerts B, De Leeuw R, Geelen J, et al. Com-parative in vitro and in vivo studies on the biologi-cal characteristics of recombinant human FSH. Endocrinology 1991;129:2623–30
   PubMed Web of Science ®Google Scholar
• Hillier S. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188–91
   PubMed Web of Science ®Google Scholar
• Chappel SC, Howles C. Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206–12
   PubMed Web of Science ®Google Scholar
• McLachlan RI, Robertson DM, Healy DL. Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function? Lancet 1986;1:1233–4
   Google Scholar
• Lockwood GM, Muttukrishna S, Groome NP, et al. Circulating inhibins and activin A during GnRH analogue down-regulation and ovarian hyperstimulation with recombinant ESH for in-vitro fertilization-embryo transfer. Clin Endo-crinol (Oxf) 1996;45:741–8
   PubMed Web of Science ®Google Scholar
• Hsueh AJW, Dahl KD, Vaughan J. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci USA 1987;84:5082–6
   Google Scholar
• Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction 2001;121:503–12
   PubMed Web of Science ®Google Scholar